These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 29088800)

  • 1. The significance of lumican expression in ovarian cancer drug-resistant cell lines.
    Klejewski A; Sterzyńska K; Wojtowicz K; Świerczewska M; Partyka M; Brązert M; Nowicki M; Zabel M; Januchowski R
    Oncotarget; 2017 Sep; 8(43):74466-74478. PubMed ID: 29088800
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased Expression of Several Collagen Genes is Associated with Drug Resistance in Ovarian Cancer Cell Lines.
    Januchowski R; Świerczewska M; Sterzyńska K; Wojtowicz K; Nowicki M; Zabel M
    J Cancer; 2016; 7(10):1295-310. PubMed ID: 27390605
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analysis of MDR genes expression and cross-resistance in eight drug resistant ovarian cancer cell lines.
    Januchowski R; Sterzyńska K; Zaorska K; Sosińska P; Klejewski A; Brązert M; Nowicki M; Zabel M
    J Ovarian Res; 2016 Oct; 9(1):65. PubMed ID: 27756418
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Microarray-based detection and expression analysis of extracellular matrix proteins in drug‑resistant ovarian cancer cell lines.
    Januchowski R; Zawierucha P; Ruciński M; Zabel M
    Oncol Rep; 2014 Nov; 32(5):1981-90. PubMed ID: 25199881
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mutual Expression of ALDH1A1, LOX, and Collagens in Ovarian Cancer Cell Lines as Combined CSCs- and ECM-Related Models of Drug Resistance Development.
    Sterzyńska K; Klejewski A; Wojtowicz K; Świerczewska M; Nowacka M; Kaźmierczak D; Andrzejewska M; Rusek D; Brązert M; Brązert J; Nowicki M; Januchowski R
    Int J Mol Sci; 2018 Dec; 20(1):. PubMed ID: 30583585
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Involvement of Lumican in Human Ovulatory Processes.
    Kedem A; Ulanenko-Shenkar K; Yung Y; Youngster M; Avraham S; Yerushalmi GM; Hourvitz A
    Reprod Sci; 2022 Feb; 29(2):366-373. PubMed ID: 34240328
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PTPRK Expression Is Downregulated in Drug Resistant Ovarian Cancer Cell Lines, and Especially in ALDH1A1 Positive CSCs-Like Populations.
    Świerczewska M; Sterzyńska K; Wojtowicz K; Kaźmierczak D; Iżycki D; Nowicki M; Zabel M; Januchowski R
    Int J Mol Sci; 2019 Apr; 20(8):. PubMed ID: 31027318
    [No Abstract]   [Full Text] [Related]  

  • 8. Microarray-based detection and expression analysis of new genes associated with drug resistance in ovarian cancer cell lines.
    Januchowski R; Sterzyńska K; Zawierucha P; Ruciński M; Świerczewska M; Partyka M; Bednarek-Rajewska K; Brązert M; Nowicki M; Zabel M; Klejewski A
    Oncotarget; 2017 Jul; 8(30):49944-49958. PubMed ID: 28611294
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Role of Matrix Gla Protein (MGP) Expression in Paclitaxel and Topotecan Resistant Ovarian Cancer Cell Lines.
    Sterzyńska K; Klejewski A; Wojtowicz K; Świerczewska M; Andrzejewska M; Rusek D; Sobkowski M; Kędzia W; Brązert J; Nowicki M; Januchowski R
    Int J Mol Sci; 2018 Sep; 19(10):. PubMed ID: 30257426
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Significance of MicroRNAs Expression in Regulation of Extracellular Matrix and Other Drug Resistant Genes in Drug Resistant Ovarian Cancer Cell Lines.
    Kazmierczak D; Jopek K; Sterzynska K; Ginter-Matuszewska B; Nowicki M; Rucinski M; Januchowski R
    Int J Mol Sci; 2020 Apr; 21(7):. PubMed ID: 32283808
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Myotilin, a New Topotecan Resistant Protein in Ovarian Cancer Cell Lines.
    Sterzyńska K; Klejewski A; Wojtowicz K; Świerczewska M; Nowicki M; Brązert J; Januchowski R
    J Cancer; 2018; 9(23):4413-4421. PubMed ID: 30519347
    [No Abstract]   [Full Text] [Related]  

  • 12. Targeted expression of a lumican transgene rescues corneal deficiencies in lumican-null mice.
    Meij JT; Carlson EC; Wang L; Liu CY; Jester JV; Birk DE; Kao WW
    Mol Vis; 2007 Oct; 13():2012-8. PubMed ID: 17982425
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The TGFBI gene and protein expression in topotecan resistant ovarian cancer cell lines.
    Wojtowicz K; Świerczewska M; Nowicki M; Januchowski R
    Adv Med Sci; 2023 Sep; 68(2):379-385. PubMed ID: 37806183
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New and Old Genes Associated with Primary and Established Responses to Cisplatin and Topotecan Treatment in Ovarian Cancer Cell Lines.
    Świerczewska M; Klejewski A; Wojtowicz K; Brązert M; Iżycki D; Nowicki M; Zabel M; Januchowski R
    Molecules; 2017 Oct; 22(10):. PubMed ID: 29027969
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Piperine Targets Different Drug Resistance Mechanisms in Human Ovarian Cancer Cell Lines Leading to Increased Sensitivity to Cytotoxic Drugs.
    Wojtowicz K; Sterzyńska K; Świerczewska M; Nowicki M; Zabel M; Januchowski R
    Int J Mol Sci; 2021 Apr; 22(8):. PubMed ID: 33921897
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of protein glycosylation reverses the MDR phenotype of cancer cell lines.
    Wojtowicz K; Januchowski R; Nowicki M; Zabel M
    Biomed Pharmacother; 2015 Aug; 74():49-56. PubMed ID: 26349962
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The significance of interferon gamma inducible protein 16 (IFI16) expression in drug resistant ovarian cancer cell lines.
    Borucka J; Sterzyńska K; Kaźmierczak D; Świerczewska M; Nowacka M; Wojtowicz K; Klejewski A; Nowicki M; Zabel M; Ramlau R; Januchowski R
    Biomed Pharmacother; 2022 Jun; 150():113036. PubMed ID: 35489285
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Altered collagen fibril formation in the sclera of lumican-deficient mice.
    Austin BA; Coulon C; Liu CY; Kao WW; Rada JA
    Invest Ophthalmol Vis Sci; 2002 Jun; 43(6):1695-701. PubMed ID: 12036967
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of Osteoblast-Specific Factor 2 (OSF-2, Periostin) Is Associated with Drug Resistance in Ovarian Cancer Cell Lines.
    Sterzyńska K; Kaźmierczak D; Klejewski A; Świerczewska M; Wojtowicz K; Nowacka M; Brązert J; Nowicki M; Januchowski R
    Int J Mol Sci; 2019 Aug; 20(16):. PubMed ID: 31412536
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Profile of MicroRNA Expression and Potential Role in the Regulation of Drug-Resistant Genes in Doxorubicin and Topotecan Resistant Ovarian Cancer Cell Lines.
    Stasiak P; Kaźmierczak D; Jopek K; Nowicki M; Rucinski M; Januchowski R
    Int J Mol Sci; 2022 May; 23(10):. PubMed ID: 35628654
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.